Inhibitor InSights, Shire’s educational program, was developed in collaboration with leading hematologists with expertise in the treatment of hemophilia patients with inhibitors. Inhibitor InSights is interactive, designed to generate meaningful clinical discussions, and is based on real-world patient cases. This facilitated discussion will focus on the distinct needs of and treatment considerations for patients and may help you when you are determining a path for your most challenging cases.
FEIBA [Anti-Inhibitor Coagulant Complex] is indicated for use in hemophilia A and B patients with inhibitors for control and prevention of bleeding episodes, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes. FEIBA is not indicated for the treatment of bleeding episodes resulting from coagulation factor deficiencies in the absence of inhibitors to coagulation factor VIII or coagulation factor IX.1
OBIZUR [Antihemophilic Factor (Recombinant), Porcine Sequence] is indicated for the treatment of bleeding episodes in adults with acquired hemophilia A. The safety and efficacy of OBIZUR has not been established in patients with baseline anti-porcine factor VIII inhibitor titer greater than 20 BU. OBIZUR is not indicated for the treatment of congenital hemophilia A or von Willebrand disease.17
Please see full detailed Important Risk Information for FEIBA and OBIZUR below.
Please note that Inhibitor InSights is not a CE or CME program.
Interested in attending one of our HCP educational programs?
Please fill in the fields below. We will contact you with more information on programs that will be conducted in your area or online.
All fields are required unless marked optional
The personally identifiable information you provide to Shire will only be used for purposes for which you have provided it. Specifically, the contact information you provided (including but not limited to email, address, and phone number) will be used to contact you about the subjects you agreed to in the check boxes above. When you submit personally identifiable information, you consent to its disclosure and use for the above purposes. We may share your information with our partners who facilitate the delivery of this information. If you ever decide that you do not wish to receive information from us regarding our programs and services, contact us at: Shire Customer Service, 1200 Lakeside Drive, Bannockburn, IL 60015 or at 1-800-423-2090. Children should get their parent’s or guardian’s consent before providing any personally identifiable information. This site does not seek to collect personal information from children under the age of 13 and will not retain this information if aware of its receipt. The privacy statement in its entirety can be accessed here.
This information is intended only for residents of the United States.